Warren, K., Burden, H., & Abrams, P. (2016). Mirabegron in overactive bladder patients: Efficacy review and update on drug safety. Ther Adv Drug Saf.
Styl cytowania ChicagoWarren, Katherine, Helena Burden, i Paul Abrams. "Mirabegron in Overactive Bladder Patients: Efficacy Review and Update On Drug Safety." Ther Adv Drug Saf 2016.
Styl cytowania MLAWarren, Katherine, Helena Burden, i Paul Abrams. "Mirabegron in Overactive Bladder Patients: Efficacy Review and Update On Drug Safety." Ther Adv Drug Saf 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..